RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cipher Pharma announces changes to its board of directors

Cipher PharmaCipher Pharmaceuticals Inc., a specialty company with a focus on dermatology, announced certain changes to its board of directors.
Article continues below

READ MORE Cipher Pharmaceuticals appoints Ralph Bohrer as U.S. president

Gerald P. McDole, Dr. William D. Claypool, Dr. Renee P. Tannenbaum and Rosemary A. Crane will stepped down from the Board.

Incumbent directors Stephen R. Wiseman, Dr. Stefan Aigner, Thomas G. Wellner and Dr. John D. Mull, will be joined on the Board by Mark Beaudet, Christian Godin and Harold Wolkin, each of whom is appointed as a director.

Mark Beaudet is a co-founder of Paladin Labs Inc., a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products, which was acquired by Endo International plc in 2014.

Since Paladin's founding in 1996, Mr. Beaudet served as a member of its board of directors and as the company's Vice President of Sales and Marketing until 2011 when he became President and Chief Executive Officer.

Following Endo's acquisition of Paladin, Mr. Beaudet joined the Endo International plc executive leadership team and continued to lead the Paladin team until his departure in June 2016.

Prior to his work with Paladin, Mr. Beaudet held marketing management positions at Procter & Gamble Canada and Pizza Hut Canada. Mr. Beaudet is a member of the board of directors of the McGill University Health Center Foundation, Loyola High School and the Loyola High School Foundation.

Mr. Beaudet also serves on the board of Altus Formulations Inc., a privately held drug formulation and development company. He is a former member of the board and former Chair of the Regulatory Affairs Committee of Innovative Medicines Canada (formerly Rx&D - Canada's Research Based Pharmaceutical Industry Association).

Mr. Beaudet holds a B.Comm in Marketing and Entrepreneurship from McGill University and is recognized as a Certified Market Research Professional (CMRP) by the Canadian Market Research and Intelligence Association and as an Accredited Pharmaceutical Manufacturer's Representative by the Council for Continuing Pharmaceutical Education (CCPE).

In 2003, Mr. Beaudet was a co-recipient of the Ernst and Young Entrepreneur of the Year award in the Quebec Life Sciences Sector. In 2015, Mr. Beaudet was inducted into the Canadian Healthcare Marketing Hall of Fame.

Christian Godin is Head of Equities at Montrusco Bolton Investments Inc. and sits on its board of directors. He is also a member of the Management Committee of Montrusco.

Prior to joining Montrusco in 2001, Mr. Godin worked for Merrill Lynch Canada where he was a director and senior equity research analyst. He also worked for Midland Walwyn Capital and CTI Capital.

Mr. Godin holds a Bachelor of Business Administration from Université du Québec à Montréal and a Master of Science in Administration specialized in Finance from HEC Montréal.

Harold Wolkin is an accomplished investment banker and financial analyst with over 30 years of experience. Mr. Wolkin joined BMO Nesbitt Burns as a senior research analyst in 1983.

He went on to serve as managing director in the Diversified Industries Group of BMO Capital Markets until January 2008.

Most recently, Mr. Wolkin served as Executive Vice-President and Head of Investment Banking for Dundee Capital Markets. Mr. Wolkin has served on a number of public company and not-for-profit boards and currently serves as a director of Diamond Estates Wines & Spirits and Baylin Technologies Inc.

He was the past President of the CFA Society of Toronto and has been a member of the Chartered Financial Institute since 1980. He is a member of the Institute of Corporate Directors.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy